SUMMARY
Immunity to pathogens is ensured through integration of early responses
mediated by innate cells and late effector functions taking place after terminal
differentiation of adaptive lymphocytes. In this context, innate lymphoid cells
(ILCs) and adaptive T cells represent a clear example of how prototypical
effector functions, including polarized expression of cytokines and/or cytotoxic
activity, can occur with overlapping modalities but different timing. The
ability of ILCs to provide early protection relies on their poised epigenetic
state, which determines their propensity to quickly respond to cytokines and to
activate specific patterns of signal-dependent transcription factors. Cytokines
activating the Janus kinases (JAKs) and members of the signal transducer and
activator of transcription (STAT) pathway are key regulators of lymphoid
development and sustain the processes underlying T cell activation and
differentiation. The role of the JAK/STAT pathway has been recently extended to
several aspects of ILC biology. Here, we discuss how JAK/STAT signals affect ILC
development and effector functions in the context of immune responses,
highlighting the molecular mechanisms involved in regulation of gene expression,
as well as, the potential of targeting the JAK/STAT pathway in inflammatory
pathologies.